- Article
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
- Michele Manganelli,
- Ilaria Grossi,
- Manuela Ferracin,
- Paola Guerriero,
- Massimo Negrini,
- Michele Ghidini,
- Chiara Senti,
- Margherita Ratti,
- Claudio Pizzo and
- Alessandro Salvi
- + 6 authors
Human hepatocellular carcinoma (HCC) is the most frequent primary tumor of the liver and the third cause of cancer-related deaths. The multikinase inhibitor sorafenib is a systemic drug for unresectable HCC. The identification of molecular biomarkers...